Cargando…

Dysregulated MicroRNA Expression in Irritable Bowel Syndrome

Detalles Bibliográficos
Autor principal:	Park, Jung Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Neurogastroenterology and Motility 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819854/ https://www.ncbi.nlm.nih.gov/pubmed/27032543 http://dx.doi.org/10.5056/jnm16044

Ejemplares similares

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

Epidemiology of irritable bowel syndrome
por: Endo, Yuka, et al.
Publicado: (2015)

Irritable Bowel Syndrome and Synbiotics
por: Kim, Soo Young
Publicado: (2019)

Irritable Bowel Syndrome and Antidepressants
por: Curtiss, Frederic R.
Publicado: (2008)

Zinc intake, microRNA dysregulation, and esophageal cancer
por: Fong, Louise Y., et al.
Publicado: (2016)

MicroRNA dysregulation influences growth hormone signaling
por: Elias, Amy E., et al.
Publicado: (2019)

Irritable Inflammatory Bowel Syndrome as a Distinct Disease Entity
por: Oh, Jung Hwan
Publicado: (2016)

Are probiotics effective in management of irritable bowel syndrome?
por: Hosseini, Asieh, et al.
Publicado: (2012)

Prevalence of Irritable Bowel Syndrome in Northern India
por: Chua, Andrew Seng Boon
Publicado: (2011)

Pathogenesis of Irritable Bowel Syndrome: Is It Really in the Gene?
por: Ghoshal, Uday C, et al.
Publicado: (2014)

The Role of Small Intestinal Bacterial Overgrowth in the Pathophysiology of Irritable Bowel Syndrome
por: Park, Hyojin
Publicado: (2010)

MicroRNA-155-5p inhibition alleviates irritable bowel syndrome by increasing claudin-1 and ZO-1 expression
por: Guo, Jian-Guo, et al.
Publicado: (2022)

Defining the irritable bowel
por: Chuah, Kee Huat, et al.
Publicado: (2022)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study
por: Stasi, Cristina, et al.
Publicado: (2017)

Prevalence and Risk Factors of Irritable Bowel Syndrome in Asia
por: Lee, Oh Young
Publicado: (2010)

Treatment of irritable bowel syndrome with probiotics: growing evidence
por: Bixquert, Miguel
Publicado: (2013)

Irritable bowel syndrome: What physicians should know?
por: Oshima, Tadayuki, et al.
Publicado: (2015)

Role of Fructose Malabsorption in Patients With Irritable Bowel Syndrome
por: Kim, Young, et al.
Publicado: (2018)

Editorial to the Special Issue “MicroRNA Dysregulation in Tumor Occurrence, Progression and Response to Therapy”
por: Iorio, Marilena V.
Publicado: (2021)

Antispasmodics in irritable bowel syndrome – a hoary old chestnut?
por: Pietrzak, Anna
Publicado: (2021)

Irritable Bowel Syndrome: A Multifaceted World Still to Discover
por: Bassotti, Gabrio
Publicado: (2022)

Irritable Bowel Syndrome or Psychiatric Disorders: Which Comes First?
por: Lee, Hong Sub
Publicado: (2022)

Current Status of Diagnosis and Treatment of Irritable Bowel Syndrome in Korea
por: Kim, You Sun
Publicado: (2023)

Dysregulation of GABAergic Signalling Contributes in the Pathogenesis of Diarrhea-predominant Irritable Bowel Syndrome
por: Aggarwal, Surbhi, et al.
Publicado: (2018)

MicroRNA-29a increased the intestinal membrane permeability of colonic epithelial cells in irritable bowel syndrome rats
por: Chao, Guanqun, et al.
Publicado: (2017)

Functional Implications and Clinical Potential of MicroRNAs in Irritable Bowel Syndrome: A Concise Review
por: Bravo-Vázquez, Luis Alberto, et al.
Publicado: (2022)

MicroRNA dysregulation in multiple sclerosis
por: Jr, Omar de Faria, et al.
Publicado: (2013)

MicroRNA regulation and dysregulation in epilepsy
por: Dogini, Danyella B., et al.
Publicado: (2013)

MicroRNA Dysregulation in Cystic Fibrosis
por: McKiernan, Paul J., et al.
Publicado: (2015)

MicroRNA Dysregulation in Prostate Cancer
por: Schitcu, Vlad Horia, et al.
Publicado: (2022)

Could Improvement in Subjective Well-being Relieve Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome?
por: Jang, Seung-Ho, et al.
Publicado: (2018)

Possible therapeutic role of IgE blockade in irritable bowel syndrome
por: Magen, Eli, et al.
Publicado: (2016)

The Rome Criteria Divides, Distorts and Dilutes the Prevalence of Irritable Bowel Syndrome
por: Gwee, Kok-Ann, et al.
Publicado: (2010)

Emerging evidence that irritable bowel syndrome & functional dyspepsia are microbial diseases
por: Talley, Nicholas J., et al.
Publicado: (2019)

The challenges of implementing evidence‐based therapy for irritable bowel syndrome in Asia
por: Chuah, Kee‐Huat, et al.
Publicado: (2021)

Prevalence of Irritable Bowel Syndrome in East Asia: Are There Differences Between Countries?
por: Shin, Cheol Min
Publicado: (2023)

Correction: MicroRNA-29a increased the intestinal membrane permeability of colonic epithelial cells in irritable bowel syndrome rats
por: Chao, Guanqun, et al.
Publicado: (2018)

Dysregulation of microRNA expression during the progression of colorectal tumors
por: Eizuka, Makoto, et al.
Publicado: (2020)

Dysregulations of MicroRNA and Gene Expression in Chronic Venous Disease
por: Zalewski, Daniel P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_783992l69v91fiuqi2bfb8t81u